CUSIP 45579U109 · who reports it, how much, and how much it matters to them
27 of the 720 hedge fund managers we track reported shares of Indivior Pharmaceuticals Inc (INDV) on Form 13F for 30 June 2026. Between them they reported USD 893m. The largest position belongs to Oaktree Capital Management, at USD 251m. The manager with the most riding on it is Mangrove Partners Im, where it is 7.2% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Oaktree Capital Management219 funds on PPLI.com | USD 251m | 3.5% |
| 2 | Madison Avenue Partners1 fund on PPLI.com | USD 118m | 5.1% |
| 3 | Mangrove Partners Im1 fund on PPLI.com | USD 110m | 7.2% |
| 4 | Citadel Advisors32 funds on PPLI.com | USD 109m | 0.0% |
| 5 | Millennium Management6 funds on PPLI.com | USD 86m | 0.0% |
| 6 | Newtyn Management3 funds on PPLI.com | USD 54m | 6.7% |
| 7 | POINT72 Asset Management17 funds on PPLI.com | USD 51m | 0.1% |
| 8 | Melqart Asset Management (UK)3 funds on PPLI.com | USD 24m | 2.3% |
| 9 | Alta Fundamental Advisers21 funds on PPLI.com | USD 17m | 5.0% |
| 10 | PFM Health Sciences3 funds on PPLI.com | USD 16m | 1.4% |
| 11 | Two Sigma Investments35 funds on PPLI.com | USD 13m | 0.0% |
| 12 | Rock Springs Capital Management2 funds on PPLI.com | USD 10m | 0.5% |
| 13 | D. E. Shaw & Co.15 funds on PPLI.com | USD 9.7m | 0.0% |
| 14 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 5.4m | 0.0% |
| 15 | Aquatic Capital Management3 funds on PPLI.com | USD 5m | 0.2% |
| 16 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 2.9m | 0.1% |
| 17 | Bridgewater Associates45 funds on PPLI.com | USD 2.8m | 0.0% |
| 18 | Exoduspoint Capital Management7 funds on PPLI.com | USD 2.1m | 0.0% |
| 19 | Capital Fund Management S.A.12 funds on PPLI.com | USD 1.5m | 0.0% |
| 20 | Balyasny Asset Management25 funds on PPLI.com | USD 1.2m | 0.0% |
| 21 | Persistent Asset Partners10 funds on PPLI.com | USD 1m | 0.3% |
| 22 | Brevan Howard Capital Management39 funds on PPLI.com | USD 497,000 | 0.0% |
| 23 | Squarepoint Ops7 funds on PPLI.com | USD 413,000 | 0.0% |
| 24 | Oxford Asset Management LLP2 funds on PPLI.com | USD 356,000 | 0.2% |
| 25 | Magnetar Financial93 funds on PPLI.com | USD 322,000 | 0.0% |
| 26 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 8,252 | 0.0% |
| 27 | Elequin Capital2 funds on PPLI.com | USD 410 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Mangrove Partners Im | USD 110m | 7.2% |
| 2 | Newtyn Management | USD 54m | 6.7% |
| 3 | Madison Avenue Partners | USD 118m | 5.1% |
| 4 | Alta Fundamental Advisers | USD 17m | 5.0% |
| 5 | Oaktree Capital Management | USD 251m | 3.5% |
| 6 | Melqart Asset Management (UK) | USD 24m | 2.3% |
| 7 | PFM Health Sciences | USD 16m | 1.4% |
| 8 | Rock Springs Capital Management | USD 10m | 0.5% |
| 9 | Persistent Asset Partners | USD 1m | 0.3% |
| 10 | Oxford Asset Management LLP | USD 356,000 | 0.2% |
Indivior Pharmaceuticals Inc trades under the symbol INDV. Its CUSIP, the code used on Form 13F, is 45579U109.
27 of the 720 hedge fund managers PPLI.com tracks reported Indivior Pharmaceuticals Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Oaktree Capital Management (USD 251m), Madison Avenue Partners (USD 118m), Mangrove Partners Im (USD 110m), Citadel Advisors (USD 109m) and Millennium Management (USD 86m).
27 managers in our coverage reported it, and between them they run 648 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Mangrove Partners Im, where the position was 7.2% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Indivior Pharmaceuticals Inc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.